0001209191-23-020480.txt : 20230322
0001209191-23-020480.hdr.sgml : 20230322
20230322160315
ACCESSION NUMBER: 0001209191-23-020480
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230320
FILED AS OF DATE: 20230322
DATE AS OF CHANGE: 20230322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEPORE PATRICK G
CENTRAL INDEX KEY: 0001055404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 23752904
MAIL ADDRESS:
STREET 1: 17-17 ROUTE 208 N
CITY: FAIRLAWN
STATE: NJ
ZIP: 07410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VYNE Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 ROUTE 202/206, SUITE 301A
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 685 ROUTE 202/206, SUITE 301A
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics Inc.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-20
0
0001566044
VYNE Therapeutics Inc.
VYNE
0001055404
LEPORE PATRICK G
C/O VYNE THERAPEUTICS INC.
685 ROUTE 202/206, SUITE 301A
BRIDGEWATER
NJ
08807
1
0
0
0
0
Common Stock
2023-03-20
4
P
0
20000
2.484
A
23472
D
The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $2.464 to $2.5199, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.
/s/ Mutya Harsch, as attorney-in-fact for Patrick G. LePore
2023-03-22